Local Coverage Determination (LCD):
Injections - Tendon, Ligament, Ganglion Cyst, Tunnel Syndromes and Morton's Neuroma (L34076)
Select the Print Complete Record, Add to Basket or Email Record Buttons to print the record, to add it to your basket or to email the record.
Printing Note:
To print an entire document, use the Need a PDF Button or the Print Complete Record Button.
Note: Documents with coding fields will include all codes in each group.
To print only the current visible page contents, use the Print Button in the page header.
Noridian Healthcare Solutions, LLC
| A and B MAC | 02101 - MAC A | J - F | Alaska
|
Noridian Healthcare Solutions, LLC
| A and B MAC | 02102 - MAC B | J - F | Alaska
|
Noridian Healthcare Solutions, LLC
| A and B MAC | 02201 - MAC A | J - F | Idaho
|
Noridian Healthcare Solutions, LLC
| A and B MAC | 02202 - MAC B | J - F | Idaho
|
Noridian Healthcare Solutions, LLC
| A and B MAC | 02301 - MAC A | J - F | Oregon
|
Noridian Healthcare Solutions, LLC
| A and B MAC | 02302 - MAC B | J - F | Oregon
|
Noridian Healthcare Solutions, LLC
| A and B MAC | 02401 - MAC A | J - F | Washington
|
Noridian Healthcare Solutions, LLC
| A and B MAC | 02402 - MAC B | J - F | Washington
|
Noridian Healthcare Solutions, LLC
| A and B MAC | 03101 - MAC A | J - F | Arizona
|
Noridian Healthcare Solutions, LLC
| A and B MAC | 03102 - MAC B | J - F | Arizona
|
Noridian Healthcare Solutions, LLC
| A and B MAC | 03201 - MAC A | J - F | Montana
|
Noridian Healthcare Solutions, LLC
| A and B MAC | 03202 - MAC B | J - F | Montana
|
Noridian Healthcare Solutions, LLC
| A and B MAC | 03301 - MAC A | J - F | North Dakota
|
Noridian Healthcare Solutions, LLC
| A and B MAC | 03302 - MAC B | J - F | North Dakota
|
Noridian Healthcare Solutions, LLC
| A and B MAC | 03401 - MAC A | J - F | South Dakota
|
Noridian Healthcare Solutions, LLC
| A and B MAC | 03402 - MAC B | J - F | South Dakota
|
Noridian Healthcare Solutions, LLC
| A and B MAC | 03501 - MAC A | J - F | Utah
|
Noridian Healthcare Solutions, LLC
| A and B MAC | 03502 - MAC B | J - F | Utah
|
Noridian Healthcare Solutions, LLC
| A and B MAC | 03601 - MAC A | J - F | Wyoming
|
Noridian Healthcare Solutions, LLC
| A and B MAC | 03602 - MAC B | J - F | Wyoming
|
Document Information
LCD ID
L34076
LCD Title
Injections - Tendon, Ligament, Ganglion Cyst, Tunnel Syndromes and Morton's Neuroma
Proposed LCD in Comment Period
N/A
AMA CPT / ADA CDT / AHA NUBC Copyright Statement
CPT codes, descriptions and other data only are copyright 2020 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
Current Dental Terminology © 2020 American Dental Association. All rights reserved.
Copyright © 2013 - 2020, the American Hospital Association, Chicago, Illinois. Reproduced by CMS with
permission. No portion of the American Hospital Association (AHA) copyrighted materials contained
within this publication may be copied without the express written consent of the AHA. AHA copyrighted
materials including the UB-04 codes and descriptions may not be removed, copied, or utilized within any
software, product, service, solution or derivative work without the written consent of the AHA. If an
entity wishes to utilize any AHA materials, please contact the AHA at 312-893-6816. Making copies or
utilizing the content of the UB-04 Manual, including the codes and/or descriptions, for internal
purposes, resale and/or to be used in any product or publication; creating any modified or derivative
work of the UB-04 Manual and/or codes and descriptions; and/or making any commercial use of UB-04
Manual or any portion thereof, including the codes and/or descriptions, is only authorized with an
express license from the American Hospital Association. To license the electronic data file of UB-04 Data
Specifications, contact Tim Carlson at (312) 893-6816. You may also contact us at ub04@aha.org.
|
Original Effective Date
For services performed on or after 10/01/2015
Revision Effective Date
For services performed on or after 10/01/2019
Revision Ending Date
N/A
Notice Period Start Date
04/06/2017
Notice Period End Date
05/21/2017
|
CMS National Coverage Policy
Title XVIII of the Social Security Act, 1862(a)(1)(A) allows coverage and payment for only those services that are considered to be medically reasonable and necessary.
Title XVIII of the Social Security Act, Section 1833(e). This section prohibits Medicare payment for any claim which lacks the necessary information to process the claim.
CMS Manual System, Pub. 100-03, Medicare National Coverage Determinations Manual, Chapter 1, Part 2, §150.7.
Coverage Indications, Limitations, and/or Medical Necessity
This policy addresses the injection of chemical substances, such as local anesthetics, steroids, sclerosing agents and/or neurolytic agents into ganglion cysts, tendon sheaths, tendon origins/insertions, ligaments or near nerves of the feet (e.g., Morton's neuroma) to affect therapy for a pathological condition.
Note: the term "Morton's neuroma" is used in this policy generically to refer to a swollen inflamed nerve in the ball of the foot, including the more specific conditions of Morton's neuroma (lesion within the third intermetatarsal space), Heuter's neuroma (first intermetatarsal space), Hauser's neuroma (second intermetatarsal space) and Iselin's neuroma (fourth intermetatarsal space). This policy applies to each.
Injection of a carpal tunnel or tarsal tunnel is indicated for the patient with a mild case of these syndromes, with or without a trial of other conservative measures, such as oral non-steroidal anti-inflammatory drugs (NSAIDs) or orthoses.
Injection into tendon sheaths, ligaments, tendon origins or insertions, ganglion cysts, neuromas or other areas described by this policy may be indicated to relieve pain or dysfunction resulting from inflammation or other pathological changes. Proper use of this modality with local anesthetics and/or steroids should be short-term, as part of an overall management plan including diagnostic evaluation, in order to clearly identify and properly treat the primary cause. In some circumstances after diagnosis has been confirmed, injection of a sclerosing or neurolytic agent may be appropriate for longer-term management.
The signs or symptoms that justify these treatments should be resolved or reevaluated after one to three injections (see reference 2 below, under "Sources of Information and Basis for Decision"). Injections beyond three to the same tendon origin/insertion, tendon sheath, ganglion, neuroma, ligament or local area in a six month period must be justified by the clinical record indicating a logical reason for failure of the prior therapy and why further treatment can reasonably be expected to succeed. A recurrence may justify a second course of therapy.
Medical necessity for injections of more than two sites at one session or for frequent or repeated injections is questionable. Such injections are likely to result in a request for medical records which must evidence careful justification of necessity.
"Dry needling" of ganglion cysts, ligaments, neuromas, tendon sheaths and their origins/insertions are non-covered procedures.
Compliance with the provisions in this policy is subject to monitoring by post payment data analysis and subsequent medical review.
Summary of Evidence
N/A
Analysis of Evidence
(Rationale for Determination)
N/A
Attachments
Related Local Coverage Documents
Related National Coverage Documents
N/A
Public Version(s)
Updated on 01/29/2020 with effective dates 10/01/2019 - N/A
Some older versions have been archived. Please visit the
MCD Archive Site to retrieve them.
- injection
- tendon
- ligament
- ganglion cyst
- tunnel morton's
- neuroma
- carpal
- tarsal